<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Transcript - Q&amp;A med Zealand Pharma]]></title><description><![CDATA[<p dir="auto">Session med CEO Emmanuel Dulac, Q4 Zealand Pharma d. 22. marts 2022</p>
<p dir="auto"><a href="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/ir/cms/QA-Zealand%20Pharma%202022-03-22.pdf" rel="nofollow ugc">https://nbg1.your-objectstorage.com/proinvestor-dev/forum/ir/cms/QA-Zealand Pharma 2022-03-22.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/443812/transcript-qa-med-zealand-pharma</link><generator>RSS for Node</generator><lastBuildDate>Thu, 02 Jul 2026 03:15:30 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/443812.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 23 Mar 2022 13:58:31 GMT</pubDate><ttl>60</ttl></channel></rss>